Presidents:

Lee L. Swanström (USA-France)

Jie He (China)

Michio Hongo (Japan)

 

OESO Website

  < back to the Program at a glance

Session 12

 

Sunday, September 3
2:00 – 4:00 pm

Room 3

 

 

Role of immune system

 

Chairs: Markus Möhler (Germany) – Sheila Krishnadath (Netherlands)

Discussant: Salah-Eddin Al-Batran (Germany)

 

Immunology part:

  • What is the role of innate immune system in esophageal cancer? Sheila K. Krishnadath (Netherlands)
  • Can the role of adaptive immune system in esophageal cancer be specified? Bastian Dislich (Germany)
  • Is there a role of Micro RNA in the immune response of esophageal cancer? Irit Ben-Aharon (Israel)
  • Overcoming tumor-mediated immunosuppression in esophageal adenocarcinoma. Hans Schlösser (Germany)
  • Is there a role for the Immunoscore in esophageal cancer? Rupert Langer (Switzerland)

Pathology part:

  • Is there a specific immune response that drives metaplasia and cancer in the esophagus?
    Sheila K. Krishnadath (Netherlands)
  • Is there a difference between East and WEST, North and South?
  • Is there a difference between Male and female?

Pathophysiology part:

  • Which animal reflux-inflammation models are there for BE and EAC? Ines Gockel (Germany)
  • Are there specific cytokines involved in metaplasia-dysplasia-cancer sequence of the esophagus?
    Gerardo Nardone (Italy)

 

Clinical part:

  • Are there compounds that enhance the immune response in esophageal cancer patients?
    Irit Ben-Aharon (Israel)
  • What are the signaling pathways that can be targeted with immunotherapies? Hans Schlösser (Germany)
  • What is the current state of immunotherapy for esophageal cancer? Maria Alsina (Israel)
  • What is the current state of combination immunotherapy? Hanoch Kashtan (Israel)

 

 







 

  Top

 

©2016 OESO – SYMPORG SA            webdesign www.architecturevisualdesign.ch